Hua Dong Selected Research

Microgels

4/2022	Assembling Microgels via Dynamic Cross-Linking Reaction Improves Printability, Microporosity, Tissue-Adhesion, and Self-Healing of Microgel Bioink for Extrusion Bioprinting.
1/2022	Dynamic Nanocomposite Microgel Assembly with Microporosity, Injectability, Tissue-Adhesion, and Sustained Drug Release Promotes Articular Cartilage Repair and Regeneration.
1/2021	In Situ Formation of Microgel Array Via Patterned Electrospun Nanofibers Promotes 3D Cell Culture and Drug Testing in a Microphysiological System.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hua Dong Research Topics

Disease

18	Neoplasms (Cancer) 01/2022 - 07/2006
9	Inflammation (Inflammations) 01/2015 - 03/2012
8	Pain (Aches) 11/2019 - 04/2011
4	Hypoxia (Hypoxemia) 01/2021 - 02/2011
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 05/2019
3	Carcinogenesis 04/2015 - 09/2013
3	Obesity 08/2014 - 06/2014
3	Hypertension (High Blood Pressure) 07/2014 - 04/2013
3	Acute Promyelocytic Leukemia 01/2009 - 08/2006
2	Tissue Adhesions 04/2022 - 01/2022
2	Insulin Resistance 01/2022 - 08/2014
2	Adenocarcinoma of Lung 11/2019 - 02/2018
2	Lung Neoplasms (Lung Cancer) 05/2019 - 01/2018
2	Glucose Intolerance 01/2019 - 01/2018
2	Primary Myelofibrosis (Myelosclerosis) 02/2018 - 03/2017
2	Colorectal Neoplasms (Colorectal Cancer) 03/2017 - 09/2015
2	Fibrosis (Cirrhosis) 10/2016 - 07/2015
2	Myocardial Infarction 01/2016 - 01/2012
2	Ventricular Remodeling 01/2016 - 01/2012
2	Neoplasm Metastasis (Metastasis) 09/2015 - 01/2013
2	Stomach Neoplasms (Stomach Cancer) 04/2015 - 11/2014
2	Pneumonia (Pneumonitis) 01/2015 - 05/2012
2	Neuralgia (Stump Neuralgia) 08/2014 - 01/2013
2	Heart Diseases (Heart Disease) 08/2014 - 01/2014
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2013 - 10/2012
2	Glioblastoma (Glioblastoma Multiforme) 12/2010 - 11/2010
1	Dementia (Dementias) 10/2022
1	Hypertrophy 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Uterine Cervical Dysplasia 01/2021
1	Ovarian Epithelial Carcinoma 12/2020
1	Vertigo (Positional Vertigo) 08/2020
1	Tooth Loss 12/2019
1	Ischemic Stroke 11/2019

Drug/Important Bio-Agent (IBA)

9	Epoxide HydrolasesIBA 07/2015 - 05/2012
5	Epoxy Compounds (Epoxides)IBA 07/2015 - 03/2012
4	Proteins (Proteins, Gene)FDA Link 12/2020 - 08/2013
4	EnzymesIBA 01/2017 - 04/2011
4	MicroRNAs (MicroRNA)IBA 10/2016 - 11/2010
4	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 06/2014 - 03/2012
4	Sodium SeleniteIBA 01/2009 - 07/2006
3	MicrogelsIBA 04/2022 - 01/2021
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2012
3	Biological ProductsIBA 05/2021 - 01/2013
3	Therapeutic UsesIBA 08/2020 - 10/2012
3	Messenger RNA (mRNA)IBA 01/2018 - 11/2010
3	4- (4- (3- (4- trifluoromethoxy- phenyl)ureido)cyclohexyloxy)benzoic acidIBA 07/2015 - 05/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2014
2	Formaldehyde (Formol)FDA Link 01/2021 - 01/2018
2	ParaffinIBA 01/2021 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2021
2	arginyl- threonyl- prolyl- prolyl- prolyl- seryl- glycine (SP 6)IBA 11/2019 - 02/2019
2	Biomarkers (Surrogate Marker)IBA 05/2019 - 11/2018
2	ruxolitinibIBA 02/2018 - 03/2017
2	simtuzumabIBA 03/2017 - 01/2017
2	Monoclonal AntibodiesIBA 01/2017 - 10/2013
2	Fatty Acids (Saturated Fatty Acids)IBA 07/2015 - 08/2014
2	Benzoic Acid (Potassium Benzoate)FDA Link 07/2015 - 05/2012
2	Angiotensin IIIBA 07/2014 - 09/2013
2	Docosahexaenoic AcidsIBA 07/2014 - 09/2013
2	brodalumabIBA 10/2013 - 10/2012
2	Dinoprostone (PGE2)FDA Link 10/2013 - 08/2013
2	CollagenIBA 10/2013 - 01/2012
2	ProstaglandinsIBA 10/2013 - 09/2013
2	Interleukin-10 (Interleukin 10)IBA 09/2013 - 10/2012
2	LipopolysaccharidesIBA 01/2013 - 04/2011
2	CaspasesIBA 01/2009 - 03/2007
1	mesoglycanIBA 10/2022
1	kartogeninIBA 01/2022
1	axicabtagene ciloleucelIBA 01/2022
1	CateninsIBA 01/2022
1	Wnt ProteinsIBA 01/2022
1	A-Form DNA (A-DNA)IBA 01/2021
1	ProdrugsIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	AcidsIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	CarbohydratesIBA 12/2020
1	Fibrinogen (Factor I)FDA Link 12/2020
1	AntigensIBA 12/2020
1	fibrin fragment D (D-dimer)IBA 12/2020
1	formycin diphosphate (FDP)IBA 12/2020
1	B7-H1 AntigenIBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	CrizotinibIBA 11/2019
1	Circulating Tumor DNAIBA 11/2019
1	Capsules (Microcapsules)IBA 11/2019
1	beta-Endorphin (Endorphin, beta)IBA 11/2019

Therapy/Procedure

8	Therapeutics 01/2022 - 07/2013
2	Aftercare (After-Treatment) 08/2020 - 11/2019
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 08/2020 - 05/2018
2	Acupuncture Points (Acupuncture Point) 02/2019 - 01/2017
1	Activities of Daily Living (ADL) 10/2022
1	Physical Therapy Modalities (Physical Therapy Technique) 10/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Radiotherapy 01/2021
1	Oral Hygiene (Dental Hygiene) 12/2019